Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Innovate Corp increases Q4 revenue significantly and reduces net loss
Innovate Corp reports Q4 2025 revenue increased 61.7% to $382.7 million with a net loss of $7.8 million, improved from $16.9 million a year earlier. The infrastructure segment drove growth with a 65.7% gain, while the life‑sciences segment suffered from inventory shortages. Cash rose to $112.1 million and MediBeacon received FDA approval for a new TGFR system. The company expects further growth from product approvals and market expansion but sees risks from supply bottlenecks and higher liabilities. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 369.41M | 79.92% |
| Gross profit | 69.66M | 80.05% |
| Net profit | 9.38M | 155.81% |
| EBITDA | 52.66M | 417.24% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €88.04M |
Number of shares | 13.64M |
52-week high/low | €19.04 - €3.35 |
| Dividends | No |
Beta | 2.44 |
P/E ratio | -3.92 |
PEG ratio | -0.03 |
P/B ratio | -0.41 |
P/S ratio | 0.06 |
Company profile
| Name | Innovate Corp |
| CEO | Paul Kenneth Voigt |
| Employees | 3,663 |
